Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections

(2016) Craig Winstanley et al.   TRENDS IN MICROBIOLOGY

Imaging regional lung function: A critical tool for developing inhaled antimicrobial therapies

(2015) Stephen Dubsky et al.   ADVANCED DRUG DELIVERY REVIEWS

Inhaled antimicrobial therapy – Barriers to effective treatment

(2015) Jeffry Weers   ADVANCED DRUG DELIVERY REVIEWS

Nebulization as a delivery method for mAbs in respiratory diseases

(2015) Renaud Respaud et al.   Expert Opinion on Drug Delivery

Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study

(2015) Rocio Rivas Caldas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Upper aero-digestive contamination by Pseudomonas aeruginosa and implications in Cystic Fibrosis

(2015) R. Rivas Caldas et al.   Journal of Cystic Fibrosis

Therapeutic Options for Hydrating Airway Mucus in Cystic Fibrosis

(2015) Bernadett E. Tildy et al.   PHARMACOLOGY

Dry powder inhalers and the right things to remember: a concept review

(2015) Roberto W Dal Negro   MULTIDISCIPLINARY RESPIRATORY MEDICINE

Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?

(2015) Aukje C. Bos et al.   PLoS One

Antimicrobial susceptibility testing in biofilm-growing bacteria

(2014) M.D. Macia et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients

(2014) Axel Dalhoff   CLINICAL MICROBIOLOGY REVIEWS

Inhaled antibiotics: dry or wet?

(2014) H. A. W. M. Tiddens et al.   EUROPEAN RESPIRATORY JOURNAL

Nebulizers for drug delivery to the lungs

(2014) Andrew R Martin et al.   Expert Opinion on Drug Delivery

300 Pseudomonas aeruginosa colonization in a CF child's upper and lower airways: a father's meticulous approach to successful eradication

(2014) A. Gerber et al.   Journal of Cystic Fibrosis

Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)

(2014) M.J. Harrison et al.   Journal of Cystic Fibrosis

Non-invasive assessment of upper and lower airway infection and inflammation in CF patients

(2014) Nele Fischer et al.   PEDIATRIC PULMONOLOGY

Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment

(2014) Julia Hentschel et al.   BMC Pulmonary Medicine

Clinical Application of Volatile Organic Compound Analysis for Detecting Infectious Diseases

(2013) S. Sethi et al.   CLINICAL MICROBIOLOGY REVIEWS

Correlation between respiratory cultures and sinus cultures in children with cystic fibrosis

(2013) Jennifer Lavin et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Manufacturing of patient‐specific optically accessible airway models by fused deposition modeling

(2013) Mathias Vermeulen et al.   RAPID PROTOTYPING JOURNAL

Bead-size directed distribution ofPseudomonas aeruginosaresults in distinct inflammatory response in a mouse model of chronic lung infection

(2012) L. J. Christophersen et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection

(2012) B. Alcala-Franco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Bacterial stress responses as determinants of antimicrobial resistance

(2012) K. Poole   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response

(2012) Helle Krogh Johansen et al.   Journal of Cystic Fibrosis

Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis

(2011) Niels Høiby   BMC Medicine

Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection

(2011) Susse Kirkelund Hansen et al.   ISME Journal

Spatial distribution of microbial communities in the cystic fibrosis lung

(2011) Dana Willner et al.   ISME Journal

Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology

(2011) David E. Geller et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

58 Route of application plays a distinct role for the outcome of a Pseudomonas aeruginosa airway infection in cystic fibrosis mouse models

(2011) A. Munder et al.   Journal of Cystic Fibrosis

The Therapeutic Potential of the Humoral Pattern Recognition Molecule PTX3 in Chronic Lung Infection Caused by Pseudomonas aeruginosa

(2011) F. Moalli et al.   JOURNAL OF IMMUNOLOGY

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis

(2011) Roger Sorde et al.   Infection and Drug Resistance

N-Glycosylation Augmentation of the Cystic Fibrosis Epithelium ImprovesPseudomonas aeruginosaClearance

(2010) Ashley T. Martino et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis

(2010) CLAUS MOSER et al.   APMIS

Bacterial distribution in lung parenchyma early after pulmonary infection with Pseudomonas aeruginosa

(2010) Andreas Schmiedl et al.   CELL AND TISSUE RESEARCH

Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis

(2010) Nina Cramer et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Pulmonary Formulations: What Remains to be Done?

(2010) Jeffry G. Weers et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Authors' reply

(2010) J G Mainz et al.   THORAX

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

Pharmacokinetics and Pharmacodynamics of Antibacterial Agents

(2009) Matthew E. Levison et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Caveolin-1 Modifies the Immunity to Pseudomonas aeruginosa

(2009) Mihaela Gadjeva et al.   JOURNAL OF IMMUNOLOGY

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations

(2009) J. L. Fothergill et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients

(2009) Thomas Bjarnsholt et al.   PEDIATRIC PULMONOLOGY

Cooperation and virulence of clinical Pseudomonas aeruginosa populations

(2009) T. Kohler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

(2009) J G Mainz et al.   THORAX

Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media

(2008) J. D. Perry et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

(2008) C.R. Hansen et al.   Journal of Cystic Fibrosis

Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants

(2008) O. Ciofu et al.   MICROBIOLOGY-SGM

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes

(2008) Sünje Johanna Pamp et al.   MOLECULAR MICROBIOLOGY

Good effect of IgY againstPseudomonas aeruginosainfections in cystic fibrosis patients

(2008) Elin Nilsson et al.   PEDIATRIC PULMONOLOGY